Salient Surgical Technologies Newswire (Page 2)

Salient Surgical Technologies Newswire (Page 2)

Comprehensive Real-Time News Feed for Salient Surgical Technologies. (Page 2)

Results 21 - 40 of 659 in Salient Surgical Technologies

  1. North America Veterinary Surgical Devices Market poised to reach USD 383.08 million by 2021Read the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    Regional and country-level analysis and forecasts of the North America Veterinary Surgical Devices Market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions those are still untapped According to the report "North America Veterinary Surgical Devices Market By Products , By Animals , By Application , And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts " published by Market Data Forecast, the North America Veterinary Surgical Devices Market was worth USD 284.24 million in 2016 and estimated to be growing at a CAGR of 6.15%, to reach USD 383.08 million by 2021.

    Comment?

  2. North America Glucose Monitoring Devices MarketRead the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    The North America Glucose Monitoring Device Market is very fast growing market and expected to reach $767.1 million by 2021 from $585.82 million in 2016, at a CAGR of 5.54% from 2016-2021. The North America rules the glucose monitoring device market with the highest market value and a share of 34% in the global market in the year 2016.

    Comment?

  3. Medtronic Announces Voluntary Recall of Diabetes Infusion SetsRead the original story w/Photo

    Tuesday Sep 12 | US Recall News

    Medtronic plc announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models of Medtronic insulin pumps. The recall is related to a certain discontinued component in these infusion sets and does not include insulin pumps or glucose sensors.

    Comment?

  4. Xact Kapitalforvaltning AB Has $19.71 Million Holdings in Medtronic PLCRead the original story w/Photo

    Tuesday Sep 12 | The Breeze

    Xact Kapitalforvaltning AB lessened its holdings in shares of Medtronic PLC by 0.1% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 222,053 shares of the medical technology company's stock after selling 114 shares during the period.

    Comment?

  5. Medtronic Announces New StealthStation(TM) Technology for Ear, Nose, and Throat ProceduresRead the original story w/Photo

    Tuesday Sep 12 | PR-inside.com

    September 12, 2017 - Medtronic plc today announced the global launch of the StealthStation ENT, a new surgical navigation system designed for surgeons treating conditions within the ear, nose, and throat anatomy. The company has received U.S. Food and Drug Administration 510k clearance and CE Mark for the system.

    Comment?

  6. Medtronic recalls diabetes infusion sets for overdose riskRead the original story w/Photo

    Monday Sep 11 | Boston.com

    Medtronic Plc is recalling a disposable device used with the company's insulin pumps, after discovering that the part can trigger an excessive dose of the drug and put patients at risk of hypoglycemia. About one in every 2 million infusion sets manufactured before April may be associated with the complication, which occurs when a membrane that's used to release pressure from inside the pump gets wet and blocks the vents, said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

    Comment?

  7. Medtronic PLC (MDT) Upgraded to Hold at Zacks Investment ResearchRead the original story w/Photo

    Sunday Sep 10 | AmericanBankingNews.com

    According to Zacks, "Apart from displaying successful integration and achievement of synergy targets, Medtronic's major business groups continue to contribute to top-line growth which highlighted sustainability across all segments and geographies. Recently, the company announced the receipt of CE Mark for Attain Stability Quad MRI SureScan Active-Fixation heart lead.

    Comment?

  8. Point72 Asset Management L.P. Takes $14.99 Million Position in Medtronic PLCRead the original story w/Photo

    Saturday Sep 9 | Daily Political

    Point72 Asset Management L.P. purchased a new position in shares of Medtronic PLC during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 186,100 shares of the medical technology company's stock, valued at approximately $14,992,000.

    Comment?

  9. Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated BalloonRead the original story

    Friday Sep 8 | PressReleasePoint

    September 8, 2017 - Medtronic plc today announced that the IN.PACT Admiral Drug-Coated Balloon received approval from the Japanese Ministry of Health, Labour and Welfare for the treatment of peripheral artery disease in the upper leg - specifically, in the thigh ) and behind the knee . Before Medtronic can begin commercialization, it must partner with Japanese MHLW to gain reimbursement to ensure broader access to this innovative and clinically-proven therapy.

    Comment?

  10. Medtronic Chairman and CEO Omar Ishrak to Speak at Morgan Stanley Global Healthcare ConferenceRead the original story

    Thursday Sep 7 | PressReleasePoint

    September 7, 2017 - Medtronic plc , the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare Conference on Monday, September 11, 2017, in New York City. Omar Ishrak, chairman and chief executive officer of Medtronic, will answer questions about the company beginning at 9:20 a.m. EDT .

    Comment?

  11. Songa Offshore SE : Warrants exercised, new shares issuedRead the original story w/Photo

    Thursday Sep 7 | PR-inside.com

    Reference is made to the stock exchange announcement on 7 April 2016 made by Songa Offshore SE regarding the new convertible bond loan issued by the Company on 17 April 2016. The Company has received exercise of 96,998 warrants and have today issued 96,998 ordinary shares in the Company.

    Comment?

  12. APRIL Financial Information // 2017 Half-year resultsRead the original story w/Photo

    Thursday Sep 7 | PR-inside.com

    Please find attached our press release regarding our 2017 Half-year results. You can download our 2017 Half-year results presentation on APRIL's website: www.april.com .

    Comment?

  13. 2021 Projections puts Latin America Varicose Vein Treatment Market at 40.17 millionRead the original story

    Thursday Sep 7 | Emailwire.com

    This report provides information about Research Methodology, Drivers, Restraints, Opportunities, Challenges Analysis,market Segmentation, Geographical Analysis, Strategic Analysis & major Leaders of Latin America Varicose Vein Treatment Market. The Latin America Varicose Vein Treatment Market was worth USD 29.05 million in 2016 and estimated to be growing at a CAGR of 6.7%, to reach USD 40.17 million by 2021.

    Comment?

  14. North America Biopsy Devices Market Share & Growth Rate Report 2016 to 2021Read the original story w/Photo

    Monday Sep 4 | PR-inside.com

    North America Biopsy Devices Market by Product, by Type and Surgical Biopsy, by Application , and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts The North America Biopsy Devices Market was worth $527 million in 2016 and estimated to be growing at a CAGR of 6.82%, to reach $733 million by 2021. North America holds the biggest share in the global biopsy device market due to increasing geriatric population.

    Comment?

  15. Monarch Capital Management Inc. Sells 1,875 Shares of Medtronic PLCRead the original story w/Photo

    Monday Sep 4 | IntersportsWire

    Monarch Capital Management Inc. lessened its stake in shares of Medtronic PLC by 2.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The firm owned 86,273 shares of the medical technology company's stock after selling 1,875 shares during the quarter.

    Comment?

  16. North America Varicose Vein Treatment Market is projected to reach USD 138.04 million by 2021Read the original story w/Photo

    Sunday Sep 3 | PR-inside.com

    North America Varicose Vein Treatment Market By Treatment , By Product And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts The North America Varicose Vein Treatment Market was worth USD 101.7 million in 2016 and estimated to be growing at a CAGR of 6.3%, to reach USD 138.04 million by 2021. The varicose vein treatment market is growing due to the increased prevalence of varicose veins.

    Comment?

  17. Medtronic PLC (MDT) Position Boosted by Caisse DE Depot ET Placement DU QuebecRead the original story w/Photo

    Saturday Sep 2 | Daily Political

    Caisse DE Depot ET Placement DU Quebec increased its stake in shares of Medtronic PLC by 4.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 8,062,172 shares of the medical technology company's stock after buying an additional 321,200 shares during the period.

    Comment?

  18. Global Blood Glucose Monitoring System Market Size by Volume and by...Read the original story

    Friday Sep 1 | Emailwire.com

    'Global Blood Glucose Monitoring System Market Outlook 2016-2021' available at Orbis Research. This report contains detailed information on clientele, applications and contact information.

    Comment?

  19. Mcdaniel Terry & Co. Sells 40 Shares of Medtronic plc.Read the original story w/Photo

    Thursday Aug 31 | Daily Political

    Mcdaniel Terry & Co. cut its position in shares of Medtronic plc. by 0.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

    Comment?

  20. View Press ReleaseRead the original story w/Photo

    Wednesday Aug 30 | Business Wire

    The deal involves substantially all the respiratory assets but excludes Competitive Bidding beneficiaries. The transaction will enhance SuperCare Health's position as the premier respiratory provider for ventilation, oxygen and pharmacy services across the state.

    Comment?